OneOme’s primary product offering is the RightMed® comprehensive test, a medication response test (also known as a pharmacogenomic test) that predicts how an individual may respond to medications, based on his or her DNA. The results may help providers make more informed, evidence-based prescription decisions and reduce medication trial and error.
With the RightMed test, providers, pharmacists, and clinical support staff get access to the RightMed Advisor (an online, interactive tool which gives providers additional insights into their patients’ results), several types of reports, and consultations with OneOme’s clinical team.
OneOme also offers its RightMed clinical decision support tool for Electronic Medical Record (EMR) integration, as well as single gene tests.
The RightMed comprehensive test is a medication response test that analyzes a patient’s DNA to determine how he or she may respond to certain medications. The test covers hundreds of medications for a wide range of medical conditions, including cancer, psychiatric conditions, chronic pain, cardiovascular disease, and more. It analyzes a large set of genes that have been shown, based on OneOme’s rigorous research* and standards for inclusion, to affect how a patient metabolizes many commonly prescribed medications.
With the RightMed test, providers, pharmacists, and clinical support staff get access to the RightMed Advisor, RightMed reports, and a clinical decision support tool that is available as an add-on:
The RightMed Advisor is an interactive tool that helps make pharmacogenomic test results clinically actionable. With the RightMed Advisor, providers, pharmacists, and clinical support staff can quickly and easily interpret test results, access OneOme’s expertly curated pharmacogenomic database, view pharmacogenomic clinical guidelines, evaluate drug-to-drug interactions, explore alternative medications, generate customized reports, and more.
When providers order the RightMed test, they receive the comprehensive test report, which includes their patients’ pharmacogenomic results for all medications covered by the test.
In addition to this report, providers can get access to several other types of reports that give them more control over what medications and/or medical specialties are included and in how much detail. By streamlining the results based on what's most relevant to the provider and the patient, these reports help providers make more informed prescription decisions, faster.
Available as an add-on to the RightMed test is OneOme’s cloud-hosted platform that integrates test results into Electronic Medical Records (EMRs). The tool provides real-time, clinically actionable prescription decision support.
If you are interested in learning more about this tool and pricing options, please CONTACT US.
Providers can place an order for a specific, single gene. Unlike the RightMed comprehensive test, the single gene test results are provided in an analytical report only, and do not include medication classification or clinical guidelines.
Single gene tests are currently available for:
NOTE: All single genes are included with the RightMed comprehensive test except for MTHFR. While MTHFR is not automatically included with a RightMed test order, it is available for providers to order as an optional and complimentary add-on. MTHFR is not available to patients who purchase the test online directly from OneOme.
Get the latest from OneOme by signing up for updates.Sign Up
Complete a simple test requisition form to place your first order.Download Form
Get more information, plus the tools you need to get started.Download Kit
Are you a patient? LEARN HOW TO GET THE RIGHTMED TEST >